MedPath

Internet Program for the Reduction of Cannabis Use

Not Applicable
Completed
Conditions
Cannabis misuse and cannabis abuse
Mental and Behavioural Disorders
Mental and behavioural disorders due to use of cannabinoids
Registration Number
ISRCTN59948178
Lead Sponsor
Swiss Office for the Coordination of Addiction Facilities - infodrog (Switzerland)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
267
Inclusion Criteria

1. Minimal age 18, either sex
2. At least once a week cannabis use in the past 30 days prior to study entry

Exclusion Criteria

1. Current serious psychiatric illness or history of psychosis, schizophrenia, bipolar type I disorder or significant current suicidal or homicidal thoughts
2. No other pharmacological or psycho-social treatment for cannabis use disorders at study entry
3. Inability to read or write in German
4. For women: pregnancy or breastfeeding

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome is the quantity of weekly cannabis use (measured in number of predefined average standard joints per week according to a consumption diary).
Secondary Outcome Measures
NameTimeMethod
1. Number of cannabis use days per week <br>2. Severity of cannabis use (CUDIT)<br>3. Severity of cannabis dependence (SDS)<br>4. Cannabis withdrawal symptoms (CWS)<br>5. Cannabis craving symptoms (CCS-7)<br>6. Other psychoactive substance use<br>7. Brief Symptom Inventory (BSI-18) <br>8. Health status (EQ-5D-L)<br>9. Treatment retention<br>10. Treatment satisfaction
© Copyright 2025. All Rights Reserved by MedPath